Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
10/2001
10/17/2001CN1073080C Process for mfg. mixed anhydrides
10/16/2001US6303785 Substituted n-cyclopropyltetrahydroisoquinolines
10/16/2001US6303639 Propanolamine derivatives substituted by heterocyclic radicals, processes for their preparation, pharmaceuticals comprising these compounds and their use
10/16/2001US6303630 Diarylsulfone non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus
10/16/2001US6303623 Bicycloloactam compounds, use thereof and intermediates for preparing thereof
10/16/2001US6303622 Benzo[c]quinolizine derivatives, their preparation and use as 5α-reductases inhibitors
10/16/2001US6303612 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxphenylsulfanylarylacetic acids
10/16/2001US6303593 For therapy human immunodeficiency virus infection, aquired immunodeficiency syndrome (aids), inflammatory and immunoregulatory disorder or disease, asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis
10/16/2001CA2025301C New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase
10/11/2001WO2001074796A1 SUCCINOYLAMINO HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
10/11/2001WO2001074763A1 Aryl and heteroaryl sulfonates
10/11/2001WO2001074753A1 Synthetic derivatives of lunularic acid, medicaments containing said compounds, method for producing the lunularic acid derivatives and the use thereof
10/11/2001WO2001074180A1 Nutritional supplements for stimulating bone growth
10/11/2001DE10015866A1 Aryl- und Heteroarylsulfonate Aryl and Heteroarylsulfonate
10/11/2001DE10015525A1 Synthetische Derivate von Lunularsäure, Arzneimittel enthaltend diese Verbindung, Verfahren zur Herstellung der Lunularsäurederivate sowie deren Verwendung Synthetic derivatives of Lunularsäure, to medicaments containing this compound, methods of making them and their use of the Lunularsäurederivate
10/11/2001CA2404545A1 Aryl and heteroaryl sulfonates
10/11/2001CA2404314A1 Succinoylamino heterocycles as inhibitors of a.beta. protein production
10/10/2001EP1142877A1 2-oxoquinoline compounds and medicinal uses thereof
10/10/2001EP1142876A1 Process for producing quinolinecarbaldehyde
10/10/2001EP1142867A2 Cell adhesion inhibitors
10/10/2001EP1140935A2 1,2-annelated quinoline derivatives
10/10/2001EP1140852A1 1,2,3,4-tetrahydronaphthalenes and their pharamaceutical use
10/10/2001EP1140851A1 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
10/10/2001EP1140850A1 Quinolinecarboxamides as antiviral agents
10/10/2001EP1140849A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
10/10/2001EP1140846A1 Aspartic protease inhibitors
10/10/2001EP1140823A1 Glucagon antagonists/inverse agonists
10/10/2001EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/10/2001EP1140791A2 Selective cpla 2 inhibitors
10/10/2001EP1140783A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
10/10/2001EP1139758A1 Fungicide mixture
10/09/2001US6300342 Antithrombotic phenylalkyl derivatives
10/09/2001US6300341 2-substituted heterocyclic sulfonamides
10/09/2001CA2018960C Salicylaldehyde derivatives and salicylic acid derivatives and their sulfur analogs, their preparation and their use as herbicides and bioregulators
10/04/2001WO2001072711A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001WO2001072685A2 Polyamine analogues as cytotoxic agents
10/04/2001WO2001072673A1 Anthracene derivatives and organic electroluminescent devices made by using the same
10/04/2001WO2001044198A8 Amphiphilic quinolylpolyamines as transfer agents for biologically active macromolecules
10/04/2001WO2001021577A3 Melanin concentrating hormone antagonist
10/04/2001US20010027200 PPARgamma modulators
10/04/2001US20010027199 Administering a Tumor Necrosis Factor-alpha inhibitor from the group of metalloproteinase inhibitors, quinolones, corticoids, thalidomide, lazaroides, pentoxyphyllines, hydroxamic and carbocyclic acids; spinal disk hernias
10/04/2001US20010027175 Inhibiting tumor necrosis factor-alpha (TNF-a) for treating nerve conditions such as sciatica by administering antiinflammatory agent etanercept or infliximab
10/04/2001EP1137647A1 Thiourea inhibitors of herpes viruses
10/04/2001EP1137645A2 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
10/04/2001EP1137633A2 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
10/04/2001EP0688314B1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use
10/04/2001CA2404662A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001CA2403814A1 Polyamine analogues as cytotoxic agents
10/03/2001CN1315942A 2-oxo-j(2H)-quinoline derivatives
10/02/2001US6297258 Useful as antineoplastic agents and in the treatment of polycystic kidney disease.
10/02/2001US6297217 Boronic ester and acid compounds, synthesis and uses
09/2001
09/27/2001WO2001070734A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
09/27/2001WO2001070698A1 Quinoline derivatives and medicinal use thereof
09/27/2001WO2001070697A1 Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and n-(4-methoxyphenyl)-3-chloropropionamide
09/27/2001WO2001070677A1 Sulphonamido-substituted bridged bicycloalkyl derivatives
09/27/2001WO2001070675A2 Inhibitors of histone deacetylase
09/27/2001WO2001070673A2 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a)
09/27/2001WO2001070364A1 Sublimation purifying method and apparatus
09/27/2001WO2001060822A8 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
09/27/2001WO2001012606B1 Tetrahydroquinoline derivatives having retinoid-like biological activity
09/27/2001US20010025047 Nitrogen containing bicyclic heteroaromatic compound containing sulfonamide and hydroxyamide groups, useful in treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, bone disease and HIV infections
09/27/2001CA2404002A1 Inhibitors of histone deacetylase
09/27/2001CA2401870A1 Cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-.alpha.
09/27/2001CA2400168A1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
09/26/2001EP1136474A1 1-Acetyl-5-bromo-4,6-dimethyl-indoline
09/26/2001EP1135372A1 Method for preparing 4-hydroquinolines and/or tautomeric compounds
09/26/2001EP1135132A2 Inhibitors of multidrug transporters
09/26/2001EP0934252B1 Amide derivatives and their use as pesticides
09/26/2001EP0802922B1 Novel amino acid derivatives, method of producing them and pharmaceutical compositions containing these compounds
09/26/2001EP0773932B1 Benzenesulfonamide derivatives used as bradykinine antagonists
09/26/2001CN1314904A Alkynyl-substituted quinoline-2-one derivatives useful as anticancer agents
09/26/2001CN1071738C Carboxylic derivatives exhibiting phospholipase A2 inhibitory activity
09/25/2001US6294552 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
09/25/2001US6294551 N-linked sulfonamides of heterocyclic thioesters
09/25/2001US6294504 Antidotes for herbicides
09/25/2001CA1341296C 2-azabicycloalkane-3-carboxylic acid derivatives, processes for their preparation, agents containing these compounds and their use
09/20/2001WO2001068593A2 Amino acid derivatives as hiv aspartyl protease inhibitors
09/20/2001WO2001068591A1 Carboxylic acid derivatives as ip antagonists
09/20/2001WO2001068588A1 POLYMER-IMMOBILIZED α-IMINOESTER
09/20/2001WO2001068585A1 Novel amide compounds
09/20/2001WO2001068186A2 Use of cyanoquinolines for treating or inhibiting colonic polyps
09/20/2001WO2000053577A9 Hydrazide inhibitors of hiv-1 integrase
09/20/2001US20010023250 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
09/20/2001CA2401821A1 Amino acid derivatives as hiv aspartyl protease inhibitors
09/19/2001EP1134219A1 Cycloalkyl-substituted aminomethylpyrrolidine derivatives
09/19/2001EP1133495A1 Semi-hydrochloride of 8-cyan-1- cyclopropyl -7-(1s,6s-2 ,8-diazabicyclo 4.3.0]nonan -8-yl)-6- fluoro-1, 4-dihydro -4-oxo-3- quinoline carboxylic acid
09/19/2001EP1133481A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
09/19/2001EP1133480A1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
09/19/2001EP1133479A1 Quinoline and quinoxaline compounds
09/19/2001EP1133474A1 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
09/19/2001CN1313280A Benzheterocyclic derivatives
09/19/2001CN1313035A Herbicidal composition and use thereof
09/18/2001US6291677 Compounds having activity as inhibitors of cytochrome P450RAI
09/18/2001US6291508 Potent ability to bind to retinoic acid receptors thus useful in treating psoriasis and rheumatoid arthritis.
09/18/2001US6291477 Tetrahydroquinolines, processes for their preparation, pharmaceutical compositions containing them, and their use to prevent or treat hyperlipoproteinaemia
09/18/2001US6291464 Aminopiperazine derivatives
09/18/2001US6291400 Herbicidal compounds
09/18/2001CA2236814C Quinoline and quinazoline compounds useful in therapy
09/18/2001CA2026890C Quinoline derivatives, their production and use
09/18/2001CA1341294C Intermediates for preparing 4-oxyquinoline-3-carboxylic acid derivatives